Is postmenopausal endometrial fluid collection alone a risk factor for endometrial cancer?


Akcay G. F. Y., TAŞ E. E., YAVUZ A. F.

Pakistan Journal of Medical Sciences, cilt.34, sa.1, ss.54-57, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.12669/pjms.341.13990
  • Dergi Adı: Pakistan Journal of Medical Sciences
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.54-57
  • Anahtar Kelimeler: Menopause, Ultrasonography, Endometrium, Uterine neoplasms, WOMEN
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

© 2018, Professional Medical Publications. All rights reserved.Objective: To determine the usefulness of single-layer, ultrasonographic measurement of endometrial fluid collection (EFC) volume to predict endometrial pathology in asymptomatic postmenopausal patients. Methods: One hundred fifty asymptomatic postmenopausal women were analysed retrospectively from January 2012 to December 2016. After patients with endometrial hyperplasia/neoplasia were included in Group-I, and those with insufficient tissue, endometrial atrophy, or endometritis were included in Group-II; Groups one and two were compared with respect to primary (correlations between endometrial thickness and EFC volume) and secondary (correlations between demographic characteristics and EFC volume) outcomes. Results: There was no correlation between EFC volume and single-layer endometrial thickness (P = 0.36). Likewise, demographic characteristics were not related to EFC (P > 0.05). However, both EFC volume and single-layer endometrial thickness were thicker in Group-I compared to Group-II (4.8±1.9 mm vs. 3.7±2.5 mm; and 5.7±9.4 mm vs. 2.7±2.5 mm, respectively) (P values were < 0.05). Conclusion: Although a cutoff value for endometrial thickness and EFC volume could not be recommended based on our study findings, it should be noted that 2% is a clinically significant rate of malignancy. Thus, postmenopausal patients with EFC should be evaluated for endometrial sampling.